IL154073A0 - Pyruvate: nadp+ oxidoreductase and uses thereof - Google Patents

Pyruvate: nadp+ oxidoreductase and uses thereof

Info

Publication number
IL154073A0
IL154073A0 IL15407301A IL15407301A IL154073A0 IL 154073 A0 IL154073 A0 IL 154073A0 IL 15407301 A IL15407301 A IL 15407301A IL 15407301 A IL15407301 A IL 15407301A IL 154073 A0 IL154073 A0 IL 154073A0
Authority
IL
Israel
Prior art keywords
nadp
oxidoreductase
pyruvate
Prior art date
Application number
IL15407301A
Other languages
English (en)
Original Assignee
Basf Plant Science Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Plant Science Gmbh filed Critical Basf Plant Science Gmbh
Publication of IL154073A0 publication Critical patent/IL154073A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL15407301A 2000-08-17 2001-08-11 Pyruvate: nadp+ oxidoreductase and uses thereof IL154073A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117730A EP1182259A1 (en) 2000-08-17 2000-08-17 Pyruvate:NADP+ oxidoreductase and uses thereof
PCT/EP2001/009317 WO2002014522A1 (en) 2000-08-17 2001-08-11 Pyruvate:nadp+ oxidoreductase and uses thereof

Publications (1)

Publication Number Publication Date
IL154073A0 true IL154073A0 (en) 2003-07-31

Family

ID=8169561

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15407301A IL154073A0 (en) 2000-08-17 2001-08-11 Pyruvate: nadp+ oxidoreductase and uses thereof

Country Status (10)

Country Link
US (1) US20040101865A1 (pt)
EP (2) EP1182259A1 (pt)
JP (1) JP2004515223A (pt)
AR (1) AR030354A1 (pt)
AU (2) AU8400901A (pt)
BR (1) BR0113309A (pt)
CA (1) CA2419020A1 (pt)
IL (1) IL154073A0 (pt)
NO (1) NO20030656L (pt)
WO (1) WO2002014522A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095636A2 (en) * 2004-03-24 2005-10-13 Aveo Pharmaceuticals, Inc. Methods for measuring enzyme activities in cells, blood, tumors and tissues
CA2680787C (en) * 2007-03-16 2015-03-03 The Regents Of The University Of California Compositions and methods for reducing h2s levels in fermented beverages
WO2008124526A1 (en) * 2007-04-03 2008-10-16 Saphire Andrew C S Methods for transforming eukaryotic algae
WO2009006386A2 (en) * 2007-06-29 2009-01-08 The Regents Of The University Of California Host cells and methods for producing isoprenyl alkanoates
JP2010263790A (ja) 2007-09-04 2010-11-25 Ajinomoto Co Inc アミノ酸生産微生物及びアミノ酸の製造法
RU2395579C2 (ru) 2007-12-21 2010-07-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТЫ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ, ПРИНАДЛЕЖАЩЕЙ К РОДУ Escherichia
CN101939412B (zh) * 2007-09-04 2016-01-20 味之素株式会社 生产氨基酸的微生物以及氨基酸的生产方法
CZ2012571A3 (cs) 2012-08-27 2013-12-11 Vysoké ucení technické v Brne Zpusob produkce polyhydroxyalkanoátu (PHA) na olejovém substrátu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955329A (en) * 1995-05-15 1999-09-21 Calgene, Inc. Engineering plant thioesterases for altered substrate specificity
WO1999000505A1 (en) * 1997-06-30 1999-01-07 The Curators Of The University Of Missouri Use of dna encoding plastid pyruvate dehydrogenase and branched chain oxoacid dehydrogenase components to enhance polyhydroxyalkanoate biosynthesis in plants
TR200100705T2 (tr) * 1998-06-26 2001-10-22 Iowa State University Research Foundation, Inc. Bitkilerde enzim ve asetil'in değiştirilmesi için yöntemler.
WO2000011199A1 (en) * 1998-08-20 2000-03-02 Pioneer Hi-Bred International, Inc. COMPOSITIONS AND METHODS FOR ALTERING AN ACETYL-CoA METABOLIC PATHWAY OF A PLANT

Also Published As

Publication number Publication date
NO20030656D0 (no) 2003-02-10
NO20030656L (no) 2003-04-14
CA2419020A1 (en) 2002-02-21
US20040101865A1 (en) 2004-05-27
AU8400901A (en) 2002-02-25
EP1182259A1 (en) 2002-02-27
AU2001284009B2 (en) 2007-07-26
AR030354A1 (es) 2003-08-20
BR0113309A (pt) 2003-07-01
EP1311694A1 (en) 2003-05-21
WO2002014522A1 (en) 2002-02-21
JP2004515223A (ja) 2004-05-27
AU2001284009B8 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001247788A1 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
AU2001282882A1 (en) Roll-formed and stamped doorbeam
EP1142988A4 (en) NEW MICROORGANISM AND USE THEREOF
MX245674B (es) 11 alfa hidroxilasa y oxidorreductasa de aspergillus ochraceus.
AU2002211717A1 (en) Stresscopins and their uses
IL154073A0 (en) Pyruvate: nadp+ oxidoreductase and uses thereof
AU2002224876A1 (en) Isolated luciferases and the use thereof
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001232332A1 (en) Leptin-resistance ameliorating agents
AU2001232075A1 (en) Compound, composition and use
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
GB0005326D0 (en) Enzymes and uses relating thereto
AU2001265384A1 (en) 52906, 33408, and 12189, potassium channel family members and uses thereof
AU2001262291A1 (en) Enzymatic oxidation composition and process
AU2001232080A1 (en) Compound, compositions and use
AU2001273452A1 (en) 47885, a novel human ubiquitin-activating enzyme and uses therefor
AU2001293291A1 (en) Two piece stamped steel pulley
AU3002901A (en) Bacterial galactanases and use thereof
AU2000251520A1 (en) Antiviral methods and compositions
AU2001275008A1 (en) 22244 and 8701, novel human dehydrogenases and uses thereof
AU2000261864A1 (en) Keyboard
AU2001247932A1 (en) 21509 and 33770, novel human dehydrogenase family members and uses thereof
AU2001251519A1 (en) Acyl-coa dehydrogenase mutant and uses thereof